End points for sickle cell disease clinical trials: renal and cardiopulmonary, cure, and low-resource settings

Ann T. Farrell, Julie Panepinto, Ankit A. Desai, Adetola A. Kassim, Jeffrey Lebensburger, Mark C. Walters, Daniel E. Bauer, Rae M. Blaylark, Donna M. DiMichele, Mark T. Gladwin, Nancy S. Green, Kathryn Hassell, Gregory J. Kato, Elizabeth S. Klings, Donald B. Kohn, Lakshmanan Krishnamurti, Jane Little, Julie Makani, Punam Malik, Patrick T. McGann, Caterina Minniti, Claudia R. Morris, Isaac Odame, Patricia Ann Oneal, Rosanna Setse, Poornima Sharma, Shalini Shenoy

Open source

DOI: 10.1182/bloodadvances.2019000883
Published: 2019-12-06
Container: Blood Advances
Publisher: American Society of Hematology
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1182/bloodadvances.2019000883,
  title = {End points for sickle cell disease clinical trials: renal and cardiopulmonary, cure, and low-resource settings},
  author = {Ann T. Farrell and Julie Panepinto and Ankit A. Desai and Adetola A. Kassim and Jeffrey Lebensburger and Mark C. Walters and Daniel E. Bauer and Rae M. Blaylark and Donna M. DiMichele and Mark T. Gladwin and Nancy S. Green and Kathryn Hassell and Gregory J. Kato and Elizabeth S. Klings and Donald B. Kohn and Lakshmanan Krishnamurti and Jane Little and Julie Makani and Punam Malik and Patrick T. McGann and Caterina Minniti and Claudia R. Morris and Isaac Odame and Patricia Ann Oneal and Rosanna Setse and Poornima Sharma and Shalini Shenoy},
  year = {2019},
  journal = {Blood Advances},
  doi = {10.1182/bloodadvances.2019000883},
  url = {https://doi.org/10.1182/bloodadvances.2019000883}
}

RIS

TY  - JOUR
TI  - End points for sickle cell disease clinical trials: renal and cardiopulmonary, cure, and low-resource settings
AU  - Ann T. Farrell
AU  - Julie Panepinto
AU  - Ankit A. Desai
AU  - Adetola A. Kassim
AU  - Jeffrey Lebensburger
AU  - Mark C. Walters
AU  - Daniel E. Bauer
AU  - Rae M. Blaylark
AU  - Donna M. DiMichele
AU  - Mark T. Gladwin
AU  - Nancy S. Green
AU  - Kathryn Hassell
AU  - Gregory J. Kato
AU  - Elizabeth S. Klings
AU  - Donald B. Kohn
AU  - Lakshmanan Krishnamurti
AU  - Jane Little
AU  - Julie Makani
AU  - Punam Malik
AU  - Patrick T. McGann
AU  - Caterina Minniti
AU  - Claudia R. Morris
AU  - Isaac Odame
AU  - Patricia Ann Oneal
AU  - Rosanna Setse
AU  - Poornima Sharma
AU  - Shalini Shenoy
PY  - 2019
JO  - Blood Advances
DO  - 10.1182/bloodadvances.2019000883
UR  - https://doi.org/10.1182/bloodadvances.2019000883
ER  -

APA

Farrell, A. T., Panepinto, J., Desai, A. A., Kassim, A. A., Lebensburger, J., Walters, M. C., Bauer, D. E., Blaylark, R. M., DiMichele, D. M., Gladwin, M. T., Green, N. S., Hassell, K., Kato, G. J., Klings, E. S., Kohn, D. B., Krishnamurti, L., Little, J., Makani, J., Malik, P., McGann, P. T., Minniti, C., Morris, C. R., Odame, I., Oneal, P. A., Setse, R., Sharma, P., & Shenoy, S. (2019). End points for sickle cell disease clinical trials: renal and cardiopulmonary, cure, and low-resource settings. Blood Advances. https://doi.org/10.1182/bloodadvances.2019000883

Source records

crossref · retrieved 2026-09-25T21:04:17.219Z